Irisinemia: A Novel Concept to Coin in Clinical Medicine?
Open Access
- 8 August 2013
- journal article
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 63 (1-2) , 60-61
Abstract
Skeletal muscle can express and release substances such as cytokines or other peptides capable of modulating metabolic processes. These cytokines, named ‘myokines', function as hormones either locally within the muscle or by targeting distant organs. A novel peptidic myokine named ‘irisin' has been recently identified. It has been noted that circulating irisin levels are lower in type 2 diabetes (T2D) compared with nondiabetic controls as well as in patients with chronic kidney disease. In addition, a negative correlation between the hemoglobin A1c (HbA1c) and circulating levels of irisin has been also observed. Thus, the blood concentration of irisin may reflect the metabolic status of patients suffering from metabolism disorders. In addition to glycemia or HbA1c, ‘irisinemia' may also become a new promising concept employed to monitor metabolic disorders such as T2D or obesity, representing a novel and useful tool in the management of metabolic diseases in the near future.Keywords
This publication has 12 references indexed in Scilit:
- Irisin is inversely associated with intrahepatic triglyceride contents in obese adultsJournal of Hepatology, 2013
- Lower circulating irisin is associated with type 2 diabetes mellitusJournal of Diabetes and its Complications, 2013
- Decrease in Irisin in Patients with Chronic Kidney DiseasePLOS ONE, 2013
- Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived ‘Browning’ Factor Irisin, Determines Insulin SensitivityPLOS ONE, 2013
- Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin ResistanceThe Journal of Clinical Endocrinology & Metabolism, 2013
- Serum irisin levels in new-onset type 2 diabetesDiabetes Research and Clinical Practice, 2013
- The Skeletal Muscle–Metabolism Axis in Prostate-Cancer TherapyNew England Journal of Medicine, 2012
- Lack of Exercise Is a Major Cause of Chronic DiseasesComprehensive Physiology, 2012
- Irisin: A new potential hormonal target for the treatment of obesity and type 2 diabetesJournal of Diabetes, 2012
- Contraction-Induced Myokine Production and Release: Is Skeletal Muscle an Endocrine Organ?Exercise and Sport Sciences Reviews, 2005